Remdesivir and COVID-19.
作者信息
Edwards Jessie K, Cole Stephen R, Adimora Adaora A
机构信息
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
出版信息
Lancet. 2020 Oct 3;396(10256):953. doi: 10.1016/S0140-6736(20)32020-1.
Abstract
摘要
相似文献
1
Remdesivir and COVID-19.瑞德西韦与新型冠状病毒肺炎
Lancet. 2020 Oct 3;396(10256):953. doi: 10.1016/S0140-6736(20)32020-1.
2
Remdesivir and COVID-19.瑞德西韦与新型冠状病毒肺炎
Lancet. 2020 Oct 3;396(10256):952. doi: 10.1016/S0140-6736(20)32021-3.
3
Remdesivir and COVID-19.瑞德西韦与新型冠状病毒肺炎
Lancet. 2020 Oct 3;396(10256):953-954. doi: 10.1016/S0140-6736(20)32019-5.
4
Remdesivir and COVID-19: What are the implications for Africa?瑞德西韦与2019冠状病毒病：对非洲有何影响？
S Afr Med J. 2020 May 7;110(6):12942.
5
[Remdesivir for patients with COVID-19].[瑞德西韦用于新型冠状病毒肺炎患者]
Internist (Berl). 2020 Aug;61(8):869-872. doi: 10.1007/s00108-020-00836-7.
6
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.支持瑞德西韦治疗新型冠状病毒感染的论据。
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
7
Efficacy of Remdesivir in COVID-19.瑞德西韦治疗新型冠状病毒肺炎的疗效
JAMA. 2020 Sep 15;324(11):1041-1042. doi: 10.1001/jama.2020.16337.
8
COVID-19 Therapeutics: Making Sense of It All.
AACN Adv Crit Care. 2020 Sep 15;31(3):239-249. doi: 10.4037/aacnacc2020792.
9
Pulmonary administration of remdesivir in the treatment of COVID-19.瑞德西韦肺部给药治疗新型冠状病毒肺炎
AAPS J. 2020 Sep 17;22(6):121. doi: 10.1208/s12248-020-00506-4.
10
Remdesivir for the Treatment of Covid-19 - Preliminary Report.瑞德西韦治疗新型冠状病毒肺炎——初步报告
N Engl J Med. 2020 Sep 3;383(10):993-994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
引用本文的文献
1
High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses.高通量筛选 FDA 批准药物库发现伊沙佐米是一种广谱抗虫病毒药物。
Viruses. 2022 Jun 24;14(7):1381. doi: 10.3390/v14071381.
Zotero 插件